NCT06055959 2026-04-13
ziMyG
UCB Pharma
Phase 2/3 Recruiting
Clinical Trials
5 trialsNCT06435312 2026-04-13
ziMyG+
UCB Pharma
Phase 3 Enrolling by invitation
NCT06471361 2026-03-27
A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT04225871 2026-02-27
RAISE-XT
UCB Pharma
Phase 3 Active not recruiting
NCT07215949 2026-02-23
Zilucoplan for Severe gMG Exacerbations
Ohio State University
Phase 3 Recruiting